US 10562960
Neutralizing antibodies to gp120 and their use
granted A61KA61K2039/505A61K2039/545
Quick answer
US patent 10562960 (Neutralizing antibodies to gp120 and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 13 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 41
- CPC classes
- A61K, A61K2039/505, A61K2039/545, A61P, A61P31/18